We have to end the social stigma associated with this disease, we have to stop blaming these people because no one chooses to be fat. All tools that enter the therapeutic field are welcome, including new drugs like GLP-1 agonists.
Eating healthily, exercising, good sleep patterns, and taking care of psychological and emotional health continue to be the cornerstone for anyone living with obesity. While new drugs like Ozempic and Wegovy are beneficial, lifestyle changes remain essential.
Obesity is not just about losing weight but about reducing excess fat that triggers metabolic alterations and increases the risk of other diseases. New drugs aim to address this comprehensively while emphasizing the importance of a healthy lifestyle.
GLP-1 agonists like Ozempic and Wegovy are not for temporary weight loss goals but are part of a comprehensive treatment approach for patients who are obese or overweight. Lifestyle changes are still crucial in managing these conditions.
[
Collection
]
[
|
...
]